Log in

Relevant bibliographies by topics / Pharmacology|Pharmaceutical sciences / Journal articles

To see the other types of publications on this topic, follow the link: Pharmacology|Pharmaceutical sciences.

Journal articles on the topic 'Pharmacology|Pharmaceutical sciences'

Author: Grafiati

Published: 9 July 2021

Last updated: 2 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Pharmacology|Pharmaceutical sciences.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Baba, Akemichi. "Pharmacology education in Faculty of Pharmaceutical Sciences, National University." Japanese Journal of Pharmacology 64 (1994): 25. http://dx.doi.org/10.1016/s0021-5198(19)49882-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Sarkar, Arindam Basu. "Journal of Pharmaceutical Sciences and Pharmacology: A New Perspective." Journal of Pharmaceutical Sciences and Pharmacology 1, no. 1 (March 1, 2014): 1–3. http://dx.doi.org/10.1166/jpsp.2014.1001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

BLAGBROUGH, IAN S., and P. NICHOLAS SHAW. "Of Medicinal Chemistry, Pharmaceutical Sciences, and Pharmaceutical Science Communications." Journal of Pharmacy and Pharmacology 48, no. 2 (February 1996): 117–18. http://dx.doi.org/10.1111/j.2042-7158.1996.tb07110.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Higashi, Taishi, Keiichi Motoyama, and Hidetoshi Arima. "Supramolecular Pharmaceutical Sciences: A Novel Concept for Future Pharmaceutical Sciences." YAKUGAKU ZASSHI 139, no. 2 (February 1, 2019): 175–83. http://dx.doi.org/10.1248/yakushi.18-00168-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Minami, Masaru, Masahiko Hirafuji, Yoshio Monma, Jun-ichi Sudo, Ryozo Yokozawa, and Toshihiko Yajima. "Pharmacology Programs at the Faculty of Pharmaceutical Sciences in Higashi-Nippon-Gakuen University." Japanese Journal of Pharmacology 64 (1994): 26. http://dx.doi.org/10.1016/s0021-5198(19)49883-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kume, Toshiaki. "Current situation and problems of pharmacology education in the Faculty of Pharmaceutical Sciences." Folia Pharmacologica Japonica 153, no. 3 (2019): 107–10. http://dx.doi.org/10.1254/fpj.153.107.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Taylor, Palmer. "Cholinergic Capsules and Academic Admonitions." Annual Review of Pharmacology and Toxicology 61, no. 1 (January 6, 2021): 25–46. http://dx.doi.org/10.1146/annurev-pharmtox-061020-050936.

Full text

Abstract:

Herein, I intend to capture highlights shared with my academic and research colleagues over the 60 years I devoted initially to my graduate and postdoctoral training and then to academic endeavors starting as an assistant professor in a new medical school at the University of California, San Diego (UCSD). During this period, the Department of Pharmacology emerged from a division within the Department of Medicine to become the first basic science department, solely within the School of Medicine at UCSD in 1979. As part of the school's plans to reorganize and to retain me at UCSD, I was appointed as founding chair. Some years later in 2002, faculty, led largely within the Department of Pharmacology and by practicing pharmacists within UCSD Healthcare, started the independent Skaggs School of Pharmacy and Pharmaceutical Sciences with a doctor of pharmacy (PharmD) program, where I served as the founding dean. My career pathway, from working at my family-owned pharmacy to chairing a department in a school of medicine and then becoming the dean of a school of pharmacy at a research-intensive, student-centered institution, involved some risky decisions. But the academic, curricular, and accreditation challenges posed were met by a cadre of creative faculty colleagues. I offer my experiences to individuals confronted with a multiplicity of real or imagined opportunities in academic health sciences, the related pharmaceutical industry, and government oversight agencies.

APA, Harvard, Vancouver, ISO, and other styles

8

Iohara, Daisuke, and Taishi Higashi. "Supramolecular Pharmaceutical Sciences: A Novel Concept Combining Pharmaceutical Sciences and Supramolecular Chemistry." YAKUGAKU ZASSHI 139, no. 2 (February 1, 2019): 141–42. http://dx.doi.org/10.1248/yakushi.18-00168-f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Lippert, Jörg, Rolf Burghaus, Andrea Edginton, Sebastian Frechen, Mats Karlsson, Andreas Kovar, Thorsten Lehr, et al. "Open Systems Pharmacology Community—An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences." CPT: Pharmacometrics & Systems Pharmacology 8, no. 12 (November 12, 2019): 878–82. http://dx.doi.org/10.1002/psp4.12473.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Setter, Stephen M., Jason L. Iltz, Jack E. Fincham, R. Keith Campbell, and Danial E. Baker. "Phosphodiesterase 5 Inhibitors for Erectile Dysfunction." Annals of Pharmacotherapy 39, no. 7-8 (July 2005): 1286–95. http://dx.doi.org/10.1345/aph.1e487.

Full text

Abstract:

OBJECTIVE To review the pharmacologic and clinical trial data of the Food and Drug Administration–approved phosphodiesterase 5 (PDE5) inhibitors for the treatment of erectile dysfunction (ED). DATA SOURCES Primary research and review articles were identified through a search of ScienceDirect, PubMed/MEDLINE, and International Pharmaceutical Abstracts (1990–August 2004). The following search terms were used in the Medicine Dentistry and Pharmacology, Toxicology, and Pharmaceutical Sciences subcategories: phosphodiesterase 5 inhibitor, PDE5 inhibitor, erectile dysfunction, sildenafil, vardenafil, tadalafil, prostatectomy, and diabetes. Web of Science (1990–August 2004) was used to search for additional abstracts using the same search terms as above. The package inserts for sildenafil, vardenafil, and tadalafil were also consulted. STUDY SELECTION AND DATA EXTRACTION All identified research, review articles, and abstracts were assessed for relevance, and all relevant information was included. Priority was given to the primary medical literature and clinical trial reports. DATA SYNTHESIS ED is a common disorder in males with increased prevalence associated with age and presence of cardiovascular disease, prostatectomy, or diabetes mellitus. Sildenafil, vardenafil, and tadalafil are selective PDE5 inhibitors currently available for treatment of ED. Their pharmacology and pharmacokinetics vary slightly, but with potentially important clinical differences in duration of activity; all have similar clinical efficacy and adverse effect profiles in patients with ED of various causes. CONCLUSIONS Sildenafil, vardenafil, and tadalafil are safe and effective PDE5 inhibitors for the treatment of ED.

APA, Harvard, Vancouver, ISO, and other styles

11

Kawaguchi, Mitsuyasu, and Atsuhiko Taniguchi. "Life-oriented Chemistry in Pharmaceutical Sciences." YAKUGAKU ZASSHI 139, no. 2 (February 1, 2019): 261–62. http://dx.doi.org/10.1248/yakushi.18-00174-f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Machado, Andreia, Araci Hack, and Maria José Sousa. "Globalization: Intersection Between Communication, Innovation and Knowledge." JOURNAL OF INTERNATIONAL BUSINESS RESEARCH AND MARKETING 4, no. 4 (2019): 22–27. http://dx.doi.org/10.18775/jibrm.1849-8558.2015.44.3003.

Full text

Abstract:

Advances in technological possibilities have made communication present in different media and spaces. By enabling interaction between different countries, by becoming a facilitator between knowledge and innovation in the globalized world, it has opened frontiers by providing innovations in various sectors of the knowledge society. In this sense, the objective in this article is to map the intersection of communication, innovation and knowledge in the globalized world. To that end, the methodology used in the research was the systematic search of literature that pointed out that the intersection is motivated by the use of innovative technologies in the process of knowledge sharing, and studies are still scarce in this area. It is possible to perceive, further, that this intersection is branched out, through Social Sciences, Business, Management and Accounting, Computer Science, Medicine, Engineering, Decision Sciences, Nursing, Arts and Humanities, Economics, Econometrics and Finance, Psychology, aligned Health Professions, Agricultural and Biological Sciences, Biochemistry, Genetics and Molecular Biology, Energy, Environmental Science, Mathematics, Materials Science, Multidisciplinary, Neuroscience, Pharmacology, Toxicology and Pharmaceutical and Veterinary.

APA, Harvard, Vancouver, ISO, and other styles

13

Sasaki, Hitoshi. "Promotion of Pharmaceutical Care and Sciences: Focus of the Japanese Society of Pharmaceutical Health Care and Sciences." YAKUGAKU ZASSHI 139, no. 3 (March 1, 2019): 405–10. http://dx.doi.org/10.1248/yakushi.18-00186-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

YOSHIDA, Hiroyuki. "Education in Graduate School of Pharmaceutical Sciences." YAKUGAKU ZASSHI 131, no. 6 (June 1, 2011): 945–47. http://dx.doi.org/10.1248/yakushi.131.945.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Ali, Mohd Akhtar, Mohd Danish, and Hamiduddin. "Contribution of al- Zahrawi (Albucasis) in the field of Pharmacy and Pharmacology with respect to his treatise Kitab al-Tasreef." International Journal of Human and Health Sciences (IJHHS) 5, no. 3 (February 6, 2021): 276. http://dx.doi.org/10.31344/ijhhs.v5i3.276.

Full text

Abstract:

Abūl-Qāsim Khalaf ibn ʿAbbās al-Zahrāwī Latinised as Abulcasis or Zahravius, lived between 936–1013 AD. He was born and raised in Al-Zahra a suburb of Córdoba (Arabic: Cortoba) in Spain. He was a famous surgeon, a talented pharmacist and a capable pharmacologist. Zahrawi is very famous for his surgical contribution, but this work explores his pharmaceutical and pharmacological contribution with respect to his treatise Kitab al-Tasreef. He served as the court physician to Caliph ʿAbd ar-Raḥmān III an-Nāṣir (912–961 AD). He wrote his famous book “Kitab al-Tasreef li-man ‘ajaza ‘an al-ta’lif” (The Arrangement of Medical Knowledge for one who is not able to compile it) around the year 1000 AD after fifty years of clinical experience. This book is also a chief source for indicating pharmaceutical contribution of al-Zahrāwī apart from the field of surgery. Twenty seven volumes, from Volume 3 to 29, of thirty volumes of the book Kitab al- Tasreef are related to Unani pharmacy and pharmacology. Ibn Abī Uṣaybiʿa (1203-1270 AD) remarked him only as an expert of pharmacy and pharmacology. Al-Zahrāwī devoted his entire life and genius to the advancement of pharmacy, medicine and surgery. He sketched a few drawings of pharmaceutical instruments and mentioned their use in his book. Significant pharmaceutical contributions of al-Zahrāwī are reflected by him through Kitab al-Tasreef which has not been highlighted, there is need to evaluate and emphasize the pharmaceutical contributions of al-Zahrāwī. This review is an attempt in this direction.International Journal of Human and Health Sciences Vol. 05 No. 03 July’21 Page: 276-285

APA, Harvard, Vancouver, ISO, and other styles

16

YOSHIYAMA, Yuji. "Development of Alternative Animal Experiments in Pharmaceutical Sciences." YAKUGAKU ZASSHI 128, no. 5 (May 1, 2008): 733–34. http://dx.doi.org/10.1248/yakushi.128.733.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Rubin, Ronald P. "The enduring legacy of Alfred Gilman senior (1908–1984) to pharmacology and clinical medicine." Journal of Medical Biography 26, no. 3 (September 28, 2016): 171–75. http://dx.doi.org/10.1177/0967772016665492.

Full text

Abstract:

Alfred Gilman was best known for his co-authorship with Louis Goodman of the seminal textbook on pharmacology The Pharmacological Basis of Therapeutics in 1941. The book made the discipline of pharmacology relevant to clinical medicine by providing a link between the basic medical sciences and the practice of medicine. Gilman was also instrumental in establishing the use of chemotherapy in the treatment of cancer and made important contributions in areas related to renal function, acid-base balance, and diuretics. During the 1960s, he created a first rate department at the newly formed Albert Einstein College of Medicine. A superb lecturer, he commented incisively on issues related to pharmacology, therapeutics, and pathophysiology. Dr Gilman also provided a key link between academia and the pharmaceutical industry by serving as a consultant to several drug firms. The legacy of Alfred Gilman senior was continued by his son, Alfred Goodman Gilman, who became a Nobel Laureate.

APA, Harvard, Vancouver, ISO, and other styles

18

TOMLINSON, ERIC. "Guest Editorial-Modern Medicines: the Converging Sciences." Journal of Pharmacy and Pharmacology 46, no. 5 (May 1994): 321. http://dx.doi.org/10.1111/j.2042-7158.1994.tb03804.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

TSUTANI, Kiichiro, and Hiroki TAKUMA. "Regulatory Sciences in Herbal Medicines and Dietary Supplements." YAKUGAKU ZASSHI 128, no. 6 (June 1, 2008): 867–80. http://dx.doi.org/10.1248/yakushi.128.867.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Marszałł, Michał Piotr. "Application of Magnetic Nanoparticles in Pharmaceutical Sciences." Pharmaceutical Research 28, no. 3 (September 22, 2010): 480–83. http://dx.doi.org/10.1007/s11095-010-0284-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Rigaldie, Y., and G. Demazeau. "Apports des hautes pressions aux sciences pharmaceutiques et médicales." Annales Pharmaceutiques Françaises 62, no. 2 (March 2004): 116–27. http://dx.doi.org/10.1016/s0003-4509(04)94290-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

OHNO, Yasuo. "Importance of Research on Alternatives to Animal Experiments in Pharmaceutical Sciences." YAKUGAKU ZASSHI 128, no. 5 (May 1, 2008): 735–40. http://dx.doi.org/10.1248/yakushi.128.735.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

SAIKI, Ikuo, Mikako YAMAZAKI, and Kinzo MATSUMOTO. "JSPS-NRCT Core University Program on Natural Medicine in Pharmaceutical Sciences." YAKUGAKU ZASSHI 129, no. 4 (April 1, 2009): 387–91. http://dx.doi.org/10.1248/yakushi.129.387.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

SHIBASAKI, Seiji, and Mitsuyoshi UEDA. "The Frontiers of White Biotechnology and the Development of Pharmaceutical Sciences." YAKUGAKU ZASSHI 130, no. 11 (November 1, 2010): 1435–36. http://dx.doi.org/10.1248/yakushi.130.1435.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

HIRASAWA, Noriyasu, and Naoto OKU. "Education of Graduate School of Pharmaceutical Sciences in New Generation: Introduction." YAKUGAKU ZASSHI 131, no. 6 (June 1, 2011): 931. http://dx.doi.org/10.1248/yakushi.131.931.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Koike, Kazuo. "Kampo Education in the Faculty of Pharmaceutical Sciences at Toho University." YAKUGAKU ZASSHI 136, no. 3 (March 1, 2016): 399–404. http://dx.doi.org/10.1248/yakushi.15-00232-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

OTO, SHIGEHIRO. "Clinical pharmacology education in pharmaceutical sciences. Introduction of 6-year pharmacopedia system. 2. From the viewpoint of pharmacy school." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 37, no. 2 (2006): 47S—48S. http://dx.doi.org/10.3999/jscpt.37.2_47s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

KOSHIMAE, HIROTOSHI. "Clinical pharmacology education in pharmaceutical sciences. Introduction of 6-year pharmacopedia system. 3. From the viewpoint of the doctor." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 37, no. 2 (2006): 49S—50S. http://dx.doi.org/10.3999/jscpt.37.2_49s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Shah, Vinod P., Luc J. R. Besancon, Pieter Stolk, Geoffrey Tucker, and Daan J. A. Crommelin. "The Pharmaceutical Sciences in 2020: Report of a Conference Organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP)." Pharmaceutical Research 27, no. 3 (January 27, 2010): 396–99. http://dx.doi.org/10.1007/s11095-009-0048-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Devinyak, Oleg, Iryna Stan, Viktoriya Syatynya, Yaroslava Deyak, Olena Lytvyn, and Ivan Kachur. "PHARMACY STUDY PLANS IN VISEGRAD GROUP COUNTRIES AND UKRAINE: A COMPARATIVE ANALYSIS." Ukrainian Scientific Medical Youth Journal 121, no. 1 (March 21, 2021): 13–21. http://dx.doi.org/10.32345/usmyj.1(121).2021.13-21.

Full text

Abstract:

Careful design of study plan is a key element of any successful educational program. Till 2018 Ministry of Health of Ukraine regulated the structure of Pharmacy study plans through the adoption of unified Ministerial study plan. Now the responsibility of educational programs and corresponding study plans design in Ukraine is fully transferred to universities. The purpose of this study is to compare the structure and content of pharmacy study plans in Visegrad Group countries with the most recent unified Pharmacy study plan in Ukraine. Methods. The official documents of Warsaw Medical University, Jagiellonian University in Krakow, Charles University, University of Veterinary and Pharmaceutical Sciences Brno, Comenius University, University of Veterinary Medicine and Pharmacy in Kosice, Semmelweis University and University of Debrecen were studied and data on required courses and corresponding ECTS credits extracted and compared with Ukrainian study plan. Results. Ukrainian unified study plan in Pharmacy pays much more attention to Humanity, Social and Economics section (9 ECTS credits plus 6 ECTS credits of Foreign Language), Computer and IT skills (8 ECTS credits), Hygiene and Ecology (3 ECTS credits), Life Safety, Labor Safety and Bioethics (6 ECTS credits in total), Extreme Medicine and Military Training (6 ECTS credits in total), Toxicological and Forensic Chemistry (4 ECTS credits), Organization and Economics of Pharmacy, Pharmaceutical Management and Marketing (12 ECTS credits in total) as compared to foreign universities. While natural science courses receive less ECTS credits in Ukraine, and some courses in rapidly evolving sciences like Molecular Biology, Immunology or Clinical Biochemistry are significantly underrepresented. Conclusions. The Pharmacy study plans of Visegrad Group universities show greater similarity with each other and tend to differ from the Ukrainian Ministerial study plan. The necessary steps to harmonize Pharmacy study plans of Ukrainian universities with V4 countries include the introduction of Molecular Biology, Immunology, Clinical Biochemistry courses, and strengthening the basic medical and chemical science courses like Human Anatomy and Physiology, Organic Chemistry, Analytical Chemistry, Pharmacology, Medicinal and Pharmaceutical Chemistry.

APA, Harvard, Vancouver, ISO, and other styles

31

(CSPS), Canadian Society for Pharmaceutical Sci. "Conference 2018: Translating Innovative Technology to Patient Care. An international symposium held jointly by CSPS, CSPT, and CC-CRS, May 22-25, 2018, Toronto, ON, Canada." Journal of Pharmacy & Pharmaceutical Sciences 21 (July 20, 2018): 1s—162s. http://dx.doi.org/10.18433/jpps30085.

Full text

Abstract:

Plenaries and Special Presentations:- Mary Haak-Frendscho, Blueline Bioscience & Versant Ventures: The View From Here: Innovation Canadian Style- David Juurlink, Sunnybrook Health Sciences Centre: The North American Opioid Crisis from 30,000 Feet- Tak Mak, Ontario Cancer Institute, Princess Margaret Hospital, Toronto: The Fourth Pillar of Cancer Treatment: It Takes a Village - Richard Weinshilboum, Mayo Clinic: Pharmacogenomics: Clinical Implementation and Future Challenges- Gordon Amidon, University of Michigan: Don’t Throw the BA/BE out with the Bathwater: (Mechanistic Oral BE) CSPS Lifetime Achievement Award: Presentation & Lecture.Conference Sessions:Special Session: Innovation and Management of Modern Pharmaceuticals1. Opioid Crisis2. Regulatory Reforms3. Crossing Biological Membranes4. Knowledge Translation - From Real World Evidence to Canadian Healthcare Needs5. Pharmaceutical Potential of Stem Cell & CRISPR-Mediated Gene Modifications6. Immuno-Oncology7. The Gut Microbiome as a Novel herapeutic Target8. Practical Pharmacology: Case Studies9. Translational Medicine10. Cannabinoids11. Innovative Biomaterials for Drug Delivery12. Pharmacogenomic Implementation13. Drug Therapy in Children

APA, Harvard, Vancouver, ISO, and other styles

32

Arnold, Mark E. "Perspectives on the draft ICH-M10 guidance: an interview with Mark Arnold." Bioanalysis 11, no. 15 (August 2019): 1379–82. http://dx.doi.org/10.4155/bio-2019-0177.

Full text

Abstract:

Biography Mark E Arnold, PhD, is Director of Science for Covance Laboratories. In that role, he develops the bioanalytical strategy for immune-, cell-based, quantitative polymerase chain reaction (qPCR) and LC–MS/MS assays to quantify drugs and metabolites, antidrug antibodies and biomarkers in animal and clinical samples for pharmacokinetic and pharmacodynamic assessments. Mark was previously Executive Director of Bioanalytical Sciences at Bristol–Myers Squibb. He received a BS (biology) from Indiana University of Pennsylvania and PhD (pharmacology) from the University of Pittsburgh. For more than 30 years, Mark has been involved in the evolving field of bioanalysis, including the science and the review and interpretation of regulations and guidance. He co-chaired the AAPS Crystal City V and VI Workshops on the US ‘FDA Draft Revised Guidance on Bioanalytical Method Validation’ and ‘Biomarkers’. He is actively involved in the Land O’Lakes Bioanalytical Conference and American Association of Pharmaceutical Scientists (AAPS, named Fellow in 2014). Mark has over 100 peer-reviewed publications, and numerous invited podium presentations. This interview was conducted by Sankeetha Nadarajah, Managing Commissioning Editor of Bioanalysis.

APA, Harvard, Vancouver, ISO, and other styles

33

TSURUO, Takashi, Gozoh TSUJIMOTO, and Hiroshi YAMAMOTO. "Introduction to the Symposium “Bio-Informatics for Pharmaceutical Sciences and Pharmacy Education”." YAKUGAKU ZASSHI 128, no. 11 (November 1, 2008): 1517. http://dx.doi.org/10.1248/yakushi.128.1517.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Okuda, Haruhiro, and Tomoko Osawa. "Education of Pharmaceutical Sciences and the Japanese Pharmacopoeia —Expectation to the Future—." YAKUGAKU ZASSHI 140, no. 6 (June 1, 2020): 757–58. http://dx.doi.org/10.1248/yakushi.19-00253-f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Miyamoto, Licht, and Hiromi Sato. "State-of-the-art Technologies Innovative to the World of Pharmaceutical Sciences." YAKUGAKU ZASSHI 140, no. 8 (August 1, 2020): 961–62. http://dx.doi.org/10.1248/yakushi.20-00012-f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Jones, David S. "Dr. Marcus Brewster: A Tribute to a Leader within the Pharmaceutical Sciences." Journal of Pharmacy and Pharmacology 68, no. 5 (May 2016): 543. http://dx.doi.org/10.1111/jphp.12572.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

KOBAYASHI, Michiya, Masako ODA, and Hiroshi SAITOH. "A Survey of the Levels of Satisfaction with Pharmacy Practice on the Third-year Students in Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido." YAKUGAKU ZASSHI 125, no. 5 (May 1, 2005): 417–25. http://dx.doi.org/10.1248/yakushi.125.417.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Foster, Brian C. "Foresight Scanning: Future Directions of Clinical and Pharmaceutical Research." Journal of Pharmacy & Pharmaceutical Sciences 11, no. 4 (January 16, 2009): 108. http://dx.doi.org/10.18433/j3nk5m.

Full text

Abstract:

Foresight Scanning: Future Directions of Clinical and Pharmaceutical Research. Brian C. Foster, Therapeutic Products Directorate, Health Canada, Ottawa, Ontario, Canada ABSTRACT The Canadian Society for Pharmaceutical Sciences Satellite Symposium on Foresight Scanning, May 26 and 27, 2008, Nordegg, Alberta, Canada, focussed on the future directions of clinical and pharmaceutical research. The symposium brought together a group of clinicians, regulatory scientists, researchers and students to examine where clinical, pharmaceutical, and regulatory science might be in 10 to 15 years. Industry, regulatory, analytical, and clinical perspectives were presented and discussed, as well as the impact of exogenous (indirect) and endogenous (direct) change drivers. Unconditional funding was provided by Bayer HealthCare; they had no input on the direction of the meeting or selection of speakers. It was envisioned that the more important endogenous drivers may not be new information or changes in technology, policy, regulation, or health care delivery, but amplification of long-term underlying trends by emergence of new technologies, convergence of existing technologies or new communication and collaboration vehicles such as Web 2.0.

APA, Harvard, Vancouver, ISO, and other styles

39

Boukhatem, Mohamed Nadjib. "Why Should you Choose to Publish your Article in International Journal of Pharmacology, Phytochemistry and Ethnomedicine?" International Journal of Pharmacology, Phytochemistry and Ethnomedicine 4 (August 2016): 1–6. http://dx.doi.org/10.18052/www.scipress.com/ijppe.4.1.

Full text

Abstract:

Choosing a scientific journal for publication of research article or review paper is a universal problem faced by all scientists and PhD students after finishing his/her scientific research. Generally, the authors of pharmaceutical and medical journals are neither paid nor do they expect any financial recompense for their publication. What then is the motivating power behind researcher’s enthusiasm to publish their paper? It is possibly, the pleasure and gratification of being an element of the progression of pharmaceutical sciences and medicine through research and successive publication.Nevertheless, the true worth of a research deception is in its citation by other scientists after publication. Thus, the paper should be read by as several researchers as possible. The aim of this editorial paper is to talk about the significant reasons that the scientist and author should consider and judge while choosing International Journal of Pharmacology, Phytochemistry and Ethnomedicine (IJPPE) for submission and publication, so as to improve and increase the probability of acceptance to add value to their research and study, and most of all guarantee an extensive distribution and readership. Then why not submit and publish your best scientific articles in IJPPE and add value to your research and paper.

APA, Harvard, Vancouver, ISO, and other styles

40

KATSURA, TOSHIYA. "Clinical pharmacology education in pharmaceutical sciences. Introduction of 6-year pharmacopedia system. 1. From the viewpoint of the hospital pharmacist." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 37, no. 2 (2006): 45S—46S. http://dx.doi.org/10.3999/jscpt.37.2_45s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Coile, Russell C., K. Wiedhaup, Ilva Bommel, Miriam Mol, Michiel Vries, E. W. Massey, J. Biller, et al. "Abstracts of papers and posters Meeting on Pharmaceutical Sciences." Pharmacy World & Science 15, S11 (December 1993): K3—K22. http://dx.doi.org/10.1007/bf01870970.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Breimer, D. D., and O. H. Postma. "The Center for Bio-Pharmaceutical Sciences: Scope and perspectives." Pharmaceutisch Weekblad Scientific Edition 7, no. 2 (April 1985): 31–33. http://dx.doi.org/10.1007/bf02106121.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

El-Kattan, Ayman F., and Manthena V. S. Varma. "Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification System." Drug Metabolism and Disposition 46, no. 5 (March 1, 2018): 729–39. http://dx.doi.org/10.1124/dmd.117.080044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

TOKUNAGA, Jin, Norito TAKAMURA, Kenji OGATA, Hiroki YOSHIDA, Kazuhiro TOTORIBE, Masashi NAGATA, Muneaki HIDAKA, et al. "Medical Emergency Education Using Emergency Care Simulators in the School of Pharmaceutical Sciences." YAKUGAKU ZASSHI 128, no. 7 (July 1, 2008): 1045–55. http://dx.doi.org/10.1248/yakushi.128.1045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

INAGAKI, Fuyuhiko. "On the Occasion of Retirement from Graduate School of Pharmaceutical Sciences, Hokkaido University." YAKUGAKU ZASSHI 130, no. 10 (October 1, 2010): 1251–62. http://dx.doi.org/10.1248/yakushi.130.1251.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Deshkar, Anuradha T., Ujwala P. Gawali, and Prashant A. Shirure. "Environmental pharmacology: an emerging science." International Journal of Basic & Clinical Pharmacology 7, no. 3 (February 22, 2018): 359. http://dx.doi.org/10.18203/2319-2003.ijbcp20180645.

Full text

Abstract:

With continuous rapid expansion of the human population there is escalating demand for resources, including human and veterinary pharmaceuticals. This has lead to rapid development of global pharmaceutical industry and with that increase in issues caused by pharmaceutical products. In recent years a great concern has been expressed over the occurrence and persistence of pharmaceutical products in the environment and their potential impact on environment. Owing to this the new branch of science called environmental pharmacology has sprouted. Environmental pharmacology deals with dispersion and impact of pharmaceutical products on environment. Solutions need to be suggested to save this only liveable planet from ill effects of these pharmaceutical products. This has given birth to the science of Ecopharmacovigilance (EPV).

APA, Harvard, Vancouver, ISO, and other styles

47

Sasaki, Shigeki, and Shiro Futaki. "Life-oriented Chemistry in Pharmaceutical Sciences^|^mdash;Chemistry Challenge to Mystery of Life^|^mdash;." YAKUGAKU ZASSHI 134, no. 4 (2014): 499–500. http://dx.doi.org/10.1248/yakushi.13-00251-f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

TOMIOKA, Yoshihisa, Noriyasu HIRASAWA, and Akira NAGANUMA. "Education for Six-years Graduate School of Pharmaceutical Sciences: A Case of Tohoku University." YAKUGAKU ZASSHI 131, no. 6 (June 1, 2011): 933–38. http://dx.doi.org/10.1248/yakushi.131.933.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Mochizuki, Mayumi. "The Report: Promotion of Social Contributions of Research on Clinical Pharmacy and Pharmaceutical Sciences." YAKUGAKU ZASSHI 139, no. 3 (March 1, 2019): 393–94. http://dx.doi.org/10.1248/yakushi.18-00186-f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Komoda, Masayo, and Michiko Yamamoto. "Academic Detailing Leading to Optimal Prescription: Supporting Prescription with Basic Pharmaceutical Sciences and Evidence." YAKUGAKU ZASSHI 139, no. 8 (August 1, 2019): 1071. http://dx.doi.org/10.1248/yakushi.19-00003-f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!